130
Participants
Start Date
February 1, 2025
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2028
Deucrictibant
Deucrictibant extended-release tablet for once daily oral use
RECRUITING
Study Site, Melbourne
RECRUITING
Study Site, St Louis
RECRUITING
Study Site, Santa Monica
RECRUITING
Study Site, Walnut Creek
RECRUITING
Study Site, Melbourne
RECRUITING
Study Site, Perth
RECRUITING
Study Site, Vienna
RECRUITING
Study Site, Sofia
RECRUITING
Study Site, Montreal
RECRUITING
Study Site, Berlin
RECRUITING
Study Site, Frankfurt
RECRUITING
Study Site, Hong Kong
RECRUITING
Study Site, Dublin
RECRUITING
Study Site, Padua
RECRUITING
Study Site, Krakow
RECRUITING
Study Site, Cape Town
RECRUITING
Study Site, Daegu
RECRUITING
Study Site, Seoul
RECRUITING
Study Site, Brighton
RECRUITING
Study Site, Bristol
RECRUITING
Study Site, Cambridge
RECRUITING
Study Site, London
RECRUITING
Study Site, Plymouth
RECRUITING
Study Site, Barcelona
Pharvaris Netherlands B.V.
INDUSTRY